Consun Pharmaceutical Group Ltd
Consun Pharmaceutical Group's GHG Emissions Data Preview
In 2023, Consun Pharmaceutical Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Consun Pharmaceutical Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Verified Sources Behind Consun Pharmaceutical Group’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Consun Pharmaceutical Group’s data sources below and access millions more through our Disclosure Search.
Insights into Consun Pharmaceutical Group's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Consun Pharmaceutical Group amounted to 79,125.22 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Consun Pharmaceutical Group increased by 9.81%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Consun Pharmaceutical Group's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Consun Pharmaceutical Group's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Consun Pharmaceutical Group were 54,210.46 metric tons of CO₂ equivalent (tCO₂e). a
Has Consun Pharmaceutical Group reduced its Scope 1 emissions over time?
Since 2020, Consun Pharmaceutical Group's Scope 1 emissions have increased by 230.17%, reflecting a rising long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2022), Consun Pharmaceutical Group's Scope 1 emissions increased by 1.87%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
What are Consun Pharmaceutical Group's Scope 2 emissions?
In 2023, Consun Pharmaceutical Group reported Scope 2 greenhouse gas (GHG) emissions of 24,914.76 tCO₂e without specifying the calculation method. a
Has Consun Pharmaceutical Group reduced its Scope 2 emissions over time?
Since 2020, Consun Pharmaceutical Group's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 61.38%, reflecting a rising long-term trend in Scope 2 emissions over time. a b
Compared to the previous year (2022), Consun Pharmaceutical Group's Scope 2 emissions (Unspecified Calculation Method) rose by 32.23% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
What methodology does Consun Pharmaceutical Group use for Scope 2 reporting?
In 2023, Consun Pharmaceutical Group reported its Scope 2 emissions using an unspecified methodology. a
Consun Pharmaceutical Group's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Consun Pharmaceutical Group’s GHG Emissions Intensity Compared to Industry Peers
In 2023, Consun Pharmaceutical Group reported Scope 1 greenhouse gas (GHG) emissions of 54,210.46 tCO₂e and total revenues of USD 398 millions. This translates into an emissions intensity of 136.27 tCO₂e per millions USD. a
Consun Pharmaceutical Group's Scope 1 Emissions Intensity Compared to Peers
How does Consun Pharmaceutical Group's GHG emissions intensity compare to its peers?
In 2023, Consun Pharmaceutical Group reported a Scope 1 emissions intensity of 136.27 tCO₂e per millions USD. Compared to the peer group median of 23.6 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Consun Pharmaceutical Group rank on GHG emissions intensity within its industry?
In 2023, Consun Pharmaceutical Group ranked 25 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Consun Pharmaceutical Group among the least efficient performers, with one of the highest emissions intensities in its sector. a